|1||NCT01720407||Recruiting||Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face||
||Other / Industry||
||268||All||18 Years and older (Adult, Older Adult)||NCT01720407||BRD/11/06-S||ImiReduc||December 2012||October 2019||October 2022||November 2, 2012||May 16, 2019||
|2||NCT00937937||Active, not recruiting
|Dinaciclib in Treating Patients With Stage IV Melanoma||
||72||All||18 Years and older (Adult, Older Adult)||NCT00937937||NCI-2011-01935
|July 1, 2009||October 22, 2013||July 13, 2009||May 6, 2019||July 22, 2016||
† Study has passed its completion date and status has not been verified in more than two years.